To establish a platform for preclinically evaluating the efficacy of anti-tumor drugs, and for studying the activated status of NF-κB in FISS, primary cells derived from FISS in three cats exhibiting similar immunohistochemical characteristics as their original tumor sites have also been established. This evidence concerns the gene NFKB1 and neoplasm.